Blizzard & Nabers

Texas-Based, National Results

AstraZeneca Promoted Seroquel as 'Weight Neutral'

Blog header
AstraZeneca Promoted Seroquel as 'Weight Neutral'
06.01.2014 News

AstraZeneca Plc advised its sales force to promote the antipsychotic drug Seroquel as “weight neutral” four years after company research found “clinically significant” weight gains in users, internal documents show ...“If 45 percent of patients gained significant weight in a year, how could that be weight-neutral?” patient attorney Ed Blizzard asked Patterson, citing a internal 1997 e-mail written by an AstraZeneca doctor.
Read More »